| ARTICLES |
|
| Year : 2000 | Volume
: 6
| Issue : 1 | Page : 37-40 |
|
|
Effect of octreotide on the prevention of hyperamylasemia after ERCP in Saudi Arabia: A prospective study
Naif Al Awad
Department of Surgery, King Faisal University, Dammam, Saudi Arabia
Correspondence Address:
Naif Al Awad
Assistant Professor in Surgery, King Fahd Hospital of the University, P.O. Box 40060, Al Khobar 31952
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
PMID: 19864727 
|
|
|
Background and objectives: Acute pancreatitis is a serious complication of ERCP. Octreotide as prophylaxis against ERCP-induced hyperamylasemia has produced conflicting results. A review article has called for additional controlled studies. This work was undertaken to see the effect of octreotide in ERCP-induced enzyme changes in a predominantly Saudi population. Subjects & methods: The setting was a university teaching hospital, Eastern Saudi Arabia. The study was prospective, randomized and controlled and the subjects were 50 consecutive adult in-patients. Octreotide, 200 tg subcutaneous, was used in the study group (27 patients). Levels of serum amylase and lipase were estimated three times post-ERCP; mean values were compared with the control group (23 patients) using student t test. Results: A total of 50 patients were studied. Their mean age was 43 (range 19 to 70); 30 were female, a male:female ratio of 1:1.5. The two groups were comparable in terms of age, sex and nationality as well as clinical, haematological and biochemical variables. In both groups, the serum levels of amylase and lipase 4 hours post-ERCP were significantly higher compared with base line levels. However, there were no statistical differences between the mean post-ERCP values within as well as between the two groups of patient studied. However, the pattern of response appeared to be different when amylase was compared with lipase. Conclusion: Prophylactic octreotide, in the regimen used in this study, does not protect against post-ERCP hyperamylasemia and hyperlipasemia. The observed apparent difference in the pattern of serum amylase and lipase remains to be confirmed. |
|
|
|
| [FULL TEXT] [PDF Not available]* |
|
 |
|
